Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025;23(10):1232-1248.
doi: 10.2174/011570159X368923250313045859.

Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson's Disease

Affiliations
Review

Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson's Disease

Si-Yuan Tian et al. Curr Neuropharmacol. 2025.

Abstract

Parkinson's disease (PD) is a prevalent neurodegenerative disorder that is characterized by both motor and non-motor symptoms. Although dopamine agonists have been demonstrated to be efficacious in the treatment of motor symptoms, their capacity to enhance non-motor symptoms remains constrained. This suggests that additional neurotransmitter systems may be involved in the pathogenesis of PD-related symptoms. The cholinergic nervous system plays a pivotal role in the central nervous system, with various projection systems associated with diverse functions, including but not limited to learning, memory, attention, posture, balance, eye movement control, and adaptation. Nevertheless, the role of the cholinergic nervous system in the motor and non-motor impairments associated with PD remains uncertain. This review elucidates the location, projection, receptors, and effects of central cholinergic systems, as well as their role in both the motor symptoms and non-motor symptoms of PD. Additionally, it examines the crosstalk between cholinergic systems and dopaminergic systems in PD pathology. A deeper comprehension of the fundamental mechanisms of the cholinergic system in PD may facilitate the development of novel therapeutic strategies.

Keywords: Parkinson’s disease; acetylcholine; cholinergic system; dopamine agonists.; motor symptoms; non-motor symptoms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest, financial or otherwise.

Similar articles

Cited by

References

    1. Conti M.M., Chambers N., Bishop C. A new outlook on cholinergic interneurons in Parkinson’s disease and L-DOPA-induced dyskinesia. Neurosci. Biobehav. Rev. 2018;92:67–82. doi: 10.1016/j.neubiorev.2018.05.021. - DOI - PubMed
    1. Jing X.Z., Yuan X.Z., Luo X., Zhang S.Y., Wang X.P. An update on nondopaminergic treatments for motor and non-motor symptoms of Parkinson’s disease. Curr. Neuropharmacol. 2023;21(8):1806–1826. doi: 10.2174/1570159X20666220222150811. - DOI - PMC - PubMed
    1. Jiang Y., Qi Z., Zhu H., Shen K., Liu R., Fang C., Lou W., Jiang Y., Yuan W., Cao X., Chen L., Zhuang Q. Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease. Neural Regen. Res. 2025;20(6):1628–1643. doi: 10.4103/NRR.NRR-D-23-01660. - DOI - PMC - PubMed
    1. Bohnen N.I., Kanel P., Koeppe R.A., Sanchez-Catasus C.A., Frey K.A., Scott P., Constantine G.M., Albin R.L., Müller M.L.T.M. Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease. Brain Commun. 2021;3(2):fcab109. doi: 10.1093/braincomms/fcab109. - DOI - PMC - PubMed
    1. Peng J.Y., Qi Z.X., Yan Q., Fan X.J., Shen K.L., Huang H.W., Lu J.H., Wang X.Q., Fang X.X., Mao L., Ni J., Chen L., Zhuang Q.X. Ameliorating parkinsonian motor dysfunction by targeting histamine receptors in entopeduncular nucleus–thalamus circuitry. Proc. Natl. Acad. Sci. USA. 2023;120(17):e2216247120. doi: 10.1073/pnas.2216247120. - DOI - PMC - PubMed

LinkOut - more resources